Self-nanoemulsifying drug delivery system for pancreatic cancer
Authors:
- Neha ParveenNPNeha Parveen
- Afsana SheikhASAfsana Sheikh
- Mohammed A.S. AbourehabMAMohammed A.S. Abourehab
- Ritu KarwasraRKRitu Karwasra
- Surender SinghSSSurender Singh
- Prashant KesharwaniPKPrashant Kesharwani
- 15 March 2023
- journal article
- research article
- Published by Elsevier in European Polymer Journal
- Vol. 190
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Design and Evaluation of Self-Nanoemulsifying Pellets of RepaglinideAAPS PharmSciTech, 2013
- Overview of the therapeutic potential of piplartine (piperlongumine)European Journal of Pharmaceutical Sciences, 2013
- Combinational therapy: New hope for pancreatic cancer?Cancer Letters, 2012
- Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathwayCancer Letters, 2011
- Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective studyInternational Journal of Clinical Oncology, 2011
- Self-emulsifying drug delivery systems: an approach to enhance oral bioavailabilityDrug Discovery Today, 2010
- In vitro Evaluation of Antiproliferative Effects of Self-assembling Nanoemulsion of Paclitaxel on Various Cancer Cell LinesNano Biomedicine and Engineering, 2010
- Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimizationInternational Journal of Pharmaceutics, 2009
- Tumor-stroma interactions in pancreatic ductal adenocarcinomaMolecular Cancer Therapeutics, 2007
- DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1Science, 1996